Alembic Limited Stock NSE India S.E.
Equities
ALEMBICLTD
INE426A01027
Real Estate Development & Operations
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.75 INR | -1.04% | +3.89% | +4.70% |
Apr. 18 | Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3% | MT |
Apr. 02 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
Sales 2022 | 782M 9.39M | Sales 2023 | 1.27B 15.28M | Capitalization | 15.22B 183M |
---|---|---|---|---|---|
Net income 2022 | 2.22B 26.67M | Net income 2023 | 1.91B 22.88M | EV / Sales 2022 | 23.4 x |
Net cash position 2022 | 270M 3.25M | Net cash position 2023 | 464M 5.57M | EV / Sales 2023 | 11.6 x |
P/E ratio 2022 |
8.37
x | P/E ratio 2023 |
7.99
x | Employees | 271 |
Yield 2022 |
2.49% | Yield 2023 |
3.71% | Free-Float | 27.91% |
1 day | -1.04% | ||
1 week | +3.89% | ||
Current month | +13.54% | ||
1 month | +17.19% | ||
3 months | +1.66% | ||
6 months | +20.93% | ||
Current year | +4.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 88-07-01 | |
Rasesh J. Shah
DFI | Director of Finance/CFO | - | 14-08-12 |
Chairman | 76 | 67-08-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 67-08-19 | |
Chief Executive Officer | 69 | 88-07-01 | |
Director/Board Member | 44 | 13-04-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 94.75 | -1.04% | 460 484 |
24-04-24 | 95.75 | +2.08% | 600,677 |
24-04-23 | 93.8 | +1.96% | 618,293 |
24-04-22 | 92 | -0.76% | 722,825 |
24-04-19 | 92.7 | +1.64% | 520,568 |
Delayed Quote NSE India S.E., April 25, 2024 at 09:03 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+31.39% | 28.38B | |
-14.74% | 26.6B | |
+23.05% | 26.54B | |
+41.97% | 23.07B | |
-6.96% | 23.03B | |
+2.90% | 19.81B | |
-6.25% | 16.96B | |
+26.13% | 16.75B | |
+18.54% | 14.92B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- ALEMBICLTD Stock